ΔRaf-1:ER* Bypasses the Cyclic AMP Block of Extracellular Signal-Regulated Kinase 1 and 2 Activation but Not CDK2 Activation or Cell Cycle Reentry

REFERENCES

• Allan, L. A., T. Duhig, M. Read, and M. Fried. 2000. The p21(WAF1/CIP1) promoter is methylated in Rat-1 cells: stable restoration of p53-dependent p21(WAF1/CIP1) expression after transfection of a genomic clone containing the p21(WAF1/CIP1) gene. Mol. Cell. Biol. 20: 1291–1298.
   PubMedGoogle Scholar
• Ally, S., T. Clair, D. Katsaros, G. Tortora, H. Yokozaki, R. A. Finch, T. L. Avery, and Y. S. Cho-Chung. 1989. Inhibition of growth and modulation of gene expression in human lung carcinoma in athymic mice by site-selective 8-Cl-cyclic adenosine monophosphate. Cancer Res. 49: 5650–5655.
   PubMed Web of Science ®Google Scholar
• Ariga, M., T. Nedachi, M. Akahori, H. Sakamoto, Y. Ito, F. Hakuno, and S. Takahashi. 2000. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells. Biochem. J. 348: 409–416.
   PubMed Web of Science ®Google Scholar
• Balmanno, K., and S. J. Cook. 1999. Sustained MAP kinase activation is required for the expression of cyclin D1, p21CIP1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 18: 3085–3097.
   PubMed Web of Science ®Google Scholar
• Baptist, M., F. Lamy, J. Gannon, T. Hunt, J. E. Dumont, and P. P. Roger. 1996. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles. J. Cell Physiol. 166: 256–273.
   PubMedGoogle Scholar
• Barlat, I., B. Henglein, A. Plet, N. Lamb, A. Fernandez, F. R. McKenzie, J. Pouyssegur, A. Vie, and J. M. Blanchard. 1995. TGF-β1 and cAMP attenuate cyclin A gene transcription via a cAMP responsive element through independent pathways. Oncogene 11: 1309–1318.
   PubMedGoogle Scholar
• Blomberg, I., and I. Hoffmann. 1999. Ectopic expression of Cdc25A accelerates the G1/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol. Cell. Biol. 19: 6183–6194.
   PubMed Web of Science ®Google Scholar
• Bortner, D. M., and M. P. Rosenberg. 1995. Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis. Cell Growth Differ. 6: 1579–1589.
   PubMedGoogle Scholar
• Burgering, B. M., G. J. Pronk, P. C. van Weeren, P. Chardin, and J. L. Bos. 1993. cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J. 12: 4211–4220.
   PubMedGoogle Scholar
• Calleja, V., P. R. Enriquez, C. Filloux, P. Peraldi, V. Baron, and E. Van Obberghen. 1997. The effect of cyclic adenosine monophosphate on the mitogen-activated protein kinase pathway depends on both the cell type and the type of tyrosine kinase-receptor. Endocrinology 138: 1111–1120.
   PubMedGoogle Scholar
• Coats, S., W. M. Flanagan, J. Nourse, and J. M. Roberts. 1996. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272: 877–880.
   PubMed Web of Science ®Google Scholar
• Connell-Crowley, L., J. W. Harper, and D. W. Goodrich. 1997. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 8: 287–301.
   PubMed Web of Science ®Google Scholar
• Cook, S. J., and F. McCormick. 1993. Inhibition by cAMP of Ras-dependent activation of Raf. Science 262: 1069–1072.
   PubMed Web of Science ®Google Scholar
• Cook, S. J., J. Beltman, K. A. Cadwallader, M. McMahon, and F. McCormick. 1997. Regulation of mitogen-activated protein kinase phosphatase-1 expression by extracellular signal-related kinase-dependent and Ca2+-dependent signal pathways in Rat-1 cells. J. Biol. Chem. 272: 13309–13319.
   PubMedGoogle Scholar
• Cook, S. J., N. Aziz, and M. McMahon. 1999. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol. Cell. Biol. 19: 330–341.
   PubMed Web of Science ®Google Scholar
• Cospedal, R., M. Lobo, and I. Zachary. 1999. Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells. Biochem. J. 342: 407–414.
   PubMedGoogle Scholar
• Davies, H., G. R. Bignell, C. Cox, P. Stephens, S. Edkins, S. Clegg, J. Teague, H. Woffendin, M. J. Garnett, W. Bottomley, N. Davis, E. Dicks, R. Ewing, Y. Floyd, K. Gray, S. Hall, R. Hawes, J. Hughes, V. Kosmidou, A. Menzies, C. Mould, A. Parker, C. Stevens, S. Watt, S. Hooper, R. Wilson, H. Jayatilake, B. A. Gusterson, C. Cooper, J. Shipley, D. Hargrave, K. Pritchard-Jones, N. Maitland, G. Chenevix-Trench, G. J. Riggins, D. D. Bigner, G. Palmieri, A. Cossu, A. Flanagan, A. Nicholson, J. W. Ho, S. Y. Leung, S. T. Yuen, B. L. Weber, H. F. Seigler, T. L. Darrow, H. Paterson, R. Marais, C. J. Marshall, R. Wooster, M. R. Stratton, and P. A. Futreal. 2002. Mutations of the BRAF gene in human cancer. Nature 417: 949–954.
   PubMed Web of Science ®Google Scholar
• DeGregori, J., G. Leone, K. Ohtani, A. Miron, and J. R. Nevins. 1995. E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev. 9: 2873–2887.
   PubMed Web of Science ®Google Scholar
• Dhillon, A. S., C. Pollock, H. Steen, P. E. Shaw, H. Mischak, and W. Kolch. 2002. Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol. Cell. Biol. 22: 3237–3246.
   PubMed Web of Science ®Google Scholar
• Dumaz, N., Y. Light, and R. Marais. 2002. Cyclic AMP blocks cell growth through Raf-1-dependent and Raf-1-independent mechanisms. Mol. Cell. Biol. 22: 3717–3728.
   PubMed Web of Science ®Google Scholar
• Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12: 2245–2262.
   PubMed Web of Science ®Google Scholar
• Enserink, J. M., A. E. Christensen, J. de Rooij, M. van Triest, F. Schwede, H. G. Genieser, S. O. Doskeland, J. L. Blank, and J. L. Bos. 2002. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat. Cell Biol. 4: 901–906.
   PubMedGoogle Scholar
• Erhardt, P., J. Troppmair, U. R. Rapp, and G. M. Cooper. 1995. Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol. Cell. Biol. 15: 5524–5530.
   PubMedGoogle Scholar
• Faure, M., and H. R. Bourne. 1995. Differential effects on cAMP on the MAP kinase cascade: evidence for a cAMP-insensitive step that can bypass Raf-1. Mol. Biol. Cell 6: 1025–1035.
   PubMedGoogle Scholar
• Gagelin, C., D. Toru-Delbauffe, J. M. Gavaret, and M. Pierre. 1999. Effects of cyclic AMP on components of the cell cycle machinery regulating DNA synthesis in cultured astrocytes. J. Neurochem. 73: 1799–1805.
   PubMedGoogle Scholar
• Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382: 511–517.
   PubMed Web of Science ®Google Scholar
• Garner, A. P., C. R. Weston, D. E. Todd, K. Balmanno, and S. J. Cook. 2002. ΔMEKK3:ER* activation induces a p38 α/β2-dependent cell cycle arrest at the G2 checkpoint. Oncogene 21: 8089–8104.
   PubMedGoogle Scholar
• Gartel, A. L., E. Goufman, S. G. Tevosian, H. Shih, A. S. Yee, and A. L. Tyner. 1998. Activation and repression of p21(WAF1/CIP1) transcription by RB binding proteins. Oncogene 17: 3463–3469.
   PubMedGoogle Scholar
• Geng, Y., W. Whoriskey, M. Y. Park, R. T. Bronson, R. H. Medema, T. Li, R. A. Weinberg, and P. Sicinski. 1999. Rescue of cyclin D1 deficiency by knockin cyclin E. Cell 97: 767–777.
   PubMed Web of Science ®Google Scholar
• Graves, L. M., K. E. Bornfeldt, E. W. Raines, B. C. Potts, S. G. Macdonald, R. Ross, and E. G. Krebs. 1993. Protein kinase A antagonizes platelet-derived growth factor-induced signalling by mitogen-activated protein kinase in human arterial smooth muscle cells. Proc. Natl. Acad. Sci. USA 90: 10300–10304.
   PubMed Web of Science ®Google Scholar
• Gu, Y., J. Rosenblatt, and D. O. Morgan. 1992. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11: 3995–4005.
   PubMed Web of Science ®Google Scholar
• Hafner, S., H. S. Adler, H. Mischak, P. Janosch, G. Heidecker, A. Wolfman, S. Pippig, M. Lohse, M. Ueffing, and W. Kolch. 1994. Mechanism of inhibition of Raf-1 by protein kinase A. Mol. Cell. Biol. 14: 6696–6703.
   PubMedGoogle Scholar
• Hoang, A. T., K. J. Cohen, J. F. Barrett, D. A. Bergstrom, and C. V. Dang. 1994. Participation of cyclin A in Myc-induced apoptosis. Proc. Natl. Acad. Sci. USA 91: 6875–6879.
   PubMedGoogle Scholar
• Hordijk, P. L., I. Verlaan, K. Jalink, E. J. van Corven, and W. H. Moolenaar. 1994. cAMP abrogates the p21 ras -mitogen-activated protein kinase pathway in fibroblasts. J. Biol. Chem. 269: 3534–3538.
   PubMedGoogle Scholar
• Houslay, M. D., and W. Kolch. 2000. Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol. Pharmacol. 58: 659–668.
   PubMedGoogle Scholar
• Jinno, S., K. Suto, A. Nagata, M. Igarashi, Y. Kanaoka, H. Nojima, and H. Okayama. 1994. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 13: 1549–1556.
   PubMed Web of Science ®Google Scholar
• Kato, J. Y., M. Matsuoka, K. Polyak, J. Massague, and C. J. Sherr. 1994. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79: 487–496.
   PubMed Web of Science ®Google Scholar
• Kerkhoff, E., and U. R. Rapp. 1998. Cell cycle targets of Ras/Raf signalling. Oncogene 17: 1457–1462.
   PubMed Web of Science ®Google Scholar
• Kikukawa, M., Y. Okamoto, H. Fukui, and H. Nakano. 1997. Effect of dibutyryl cyclic AMP on the cyclin-dependent kinase inhibitor p27Kip1 in the human hepatoma cells PLC/PRF/5. Anticancer Res. 17: 3287–3291.
   PubMedGoogle Scholar
• Kim, T. Y., W. I. Kim, R. E. Smith, and E. D. Kay. 2001. Role of p27(Kip1) in cAMP- and TGF-beta2-mediated antiproliferation in rabbit corneal endothelial cells. Investig. Ophthalmol. Vis. Sci. 42: 3142–3149.
   PubMed Web of Science ®Google Scholar
• Kolch, W. 2000. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 351: 289–305.
   PubMed Web of Science ®Google Scholar
• LaBaer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11: 847–862.
   PubMed Web of Science ®Google Scholar
• L'Allemain, G., J. N. Lavoie, N. Rivard, V. Baldin, and J. Pouyssegur. 1997. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle re-entry in fibroblasts Oncogene 14: 1981–1990.
   PubMedGoogle Scholar
• Lee, T. H., L. Y. Chuang, and W. C. Hung. 2000. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells. Oncogene 19: 3766–3773.
   PubMed Web of Science ®Google Scholar
• Lee, Y. H., J. S. Park, C. H. Park, and S. K. Lee. 1998. Synergistic effect of cyclic AMP and insulin on the expression of cyclin A gene in Swiss 3T3 cells. Biochem. Biophys. Res. Commun. 244: 843–848.
   PubMedGoogle Scholar
• Lerner, A., D. H. Kim, and R. Lee. 2000. The cAMP signaling pathway as a therapeutic target in lymphoid malignancies. Leuk. Lymphoma 37: 39–51.
   PubMed Web of Science ®Google Scholar
• Lewis, T. S., P. S. Shapiro, and N. G. Ahn. 1998. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74: 49–139.
   PubMed Web of Science ®Google Scholar
• Littlewood, T. D., D. C. Hancock, P. S. Danielian, M. G. Parker, and G. I. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23: 1686–1690.
   PubMed Web of Science ®Google Scholar
• Lomazzi, M., M. C. Moroni, M. R. Jensen, E. Frittoli, and K. Helin. 2002. Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry. Nat. Genet. 31: 190–194.
   PubMedGoogle Scholar
• Magnaldo, I., J. Pouyssegur, and S. Paris. 1989. Cyclic AMP inhibits mitogen-induced DNA synthesis in hamster fibroblasts, regardless of the signalling pathway involved. FEBS Lett. 245: 65–69.
   PubMedGoogle Scholar
• Marshall, C. J. 1999. How do small GTPase signal transduction pathways regulate cell cycle entry? Curr. Opin. Cell Biol. 11: 732–736.
   PubMedGoogle Scholar
• McKenzie, F. R., and J. Pouyssegur. 1996. cAMP-mediated growth inhibition in fibroblasts is not mediated via mitogen-activated protein (MAP) kinase (ERK) inhibition. cAMP-dependent protein kinase induces a temporal shift in growth factor-stimulated MAP kinases. J. Biol. Chem. 271: 13476–13483.
   PubMed Web of Science ®Google Scholar
• Mischak, H., T. Seitz, P. Janosch, M. Eulitz, H. Steen, M. Schellerer, A. Philipp, and W. Kolch. 1996. Negative regulation of Raf-1 by phosphorylation of serine 621. Mol. Cell. Biol. 16: 5409–5418.
   PubMedGoogle Scholar
• Morrison, D. K., G. Heidecker, U. R. Rapp, and T. D. Copeland. 1993. Identification of the major phosphorylation sites of the Raf-1 kinase. J. Biol. Chem. 268: 17309–17316.
   PubMedGoogle Scholar
• Nilsson, I., and I. Hoffmann. 2000. Cell cycle regulation by the Cdc25 phosphatase family. Prog. Cell Cycle Res. 4: 107–114.
   PubMedGoogle Scholar
• Palmero, I., and G. Peters. 1996. Perturbation of cell cycle regulators in human cancer. Cancer Surv. 27: 351–367.
   PubMedGoogle Scholar
• Pastan, I. H., G. S. Johnson, and W. B. Anderson. 1975. Role of cyclic nucleotides in growth control. Annu. Rev. Biochem. 44: 491–522.
   PubMed Web of Science ®Google Scholar
• Rao, S., J. Gray-Bablin, T. W. Herliczek, and K. Keyomarsi. 1999. The biphasic induction of p21 and p27 in breast cancer cells by modulators of cAMP is posttranscriptionally regulated and independent of the PKA pathway. Exp. Cell Res. 252: 211–223.
   PubMedGoogle Scholar
• Robinson, M. J., and M. H. Cobb. 1997. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9: 180–186.
   PubMed Web of Science ®Google Scholar
• Roger, P. P., D. Christophe, J. E. Dumont, and I. Pirson. 1997. The dog thyroid primary culture system: a model of the regulation of function, growth and differentiation expression by cAMP and other well-defined signaling cascades. Eur. J. Endocrinol. 137: 579–598.
   PubMedGoogle Scholar
• Samuels, M. L., M. J. Weber, J. M. Bishop, and M. McMahon. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol. Cell. Biol. 13: 6241–6252.
   PubMed Web of Science ®Google Scholar
• Santoni-Rugiu, E., J. Falck, N. Mailand, J. Bartek, and J. Lukas. 2000. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway. Mol. Cell. Biol. 20: 3497–3509.
   PubMed Web of Science ®Google Scholar
• Sewing, A., C. Burger, S. Brusselbach, C. Schalk, F. C. Lucibello, and R. Muller. 1993. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J. Cell Sci. 104: 545–555.
   PubMed Web of Science ®Google Scholar
• Schmitt, J. M., and P. J. S. Stork. 2001. Cyclic AMP-mediated inhibition of cell growth requires the small G protein Rap1. Mol. Cell. Biol. 21: 3671–3683.
   PubMed Web of Science ®Google Scholar
• Shaulian, E., and M. Karin. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4: E131–E136.
   PubMed Web of Science ®Google Scholar
• Sidovar, M. F., P. Kozlowski, J. W. Lee, M. A. Collins, Y. He, and L. M. Graves. 2000. Phosphorylation of serine 43 is not required for inhibition of c-Raf kinase by the cAMP-dependent protein kinase. J. Biol. Chem. 275: 28688–28694.
   PubMed Web of Science ®Google Scholar
• Solomon, M. J., M. Glotzer, T. H. Lee, M. Philippe, and M. W. Kirschner. 1990. Cyclin activation of p34cdc2. Cell 63: 1013–1024.
   PubMed Web of Science ®Google Scholar
• Squires, M. S., P. M. Nixon, and S. J. Cook. 2002. Cell cycle arrest by PD184352 requires inhibition of the extracellular signal-regulated kinases (ERK) 1/2 but not ERK5/BMK1. Biochem. J. 366: 673–680.
   PubMed Web of Science ®Google Scholar
• Stork, P. J. S., and J. M. Schmitt. 2002. Crosstalk between cAMP and MAP kinase signalling in the regulation of cell proliferation. Trends Cell Biol. 12: 258–266.
   PubMed Web of Science ®Google Scholar
• Tortora, G., F. Ciardiello, S. Ally, T. Clair, D. S. Salomon, and Y. S. Cho-Chung. 1989. Site-selective 8-chloroadenosine 3′,5′-cyclic monophosphate inhibits transformation and transforming growth factor alpha production in Ki-ras-transformed rat fibroblasts. FEBS Lett. 242: 363–367.
   PubMed Web of Science ®Google Scholar
• Treinies, I., H. F. Paterson, S. Hooper, R. Wilson, and C. J. Marshall. 1999. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis. Mol. Cell. Biol. 19: 321–329.
   PubMedGoogle Scholar
• Vadiveloo, P. K., E. L. Filonzi, H. R. Stanton, and J. A. Hamilton. 1997. G1 phase arrest of human smooth muscle cells by heparin, IL-4 and cAMP is linked to repression of cyclin D1 and cdk2. Atherosclerosis 133: 61–69.
   PubMedGoogle Scholar
• Van Keymeulen, A., J. Bartek, J. E. Dumont, and P. P. Roger. 1999. Cyclin D3 accumulation and activity integrate and rank the comitogenic pathways of thyrotropin and insulin in thyrocytes in primary culture. Oncogene 18: 7351–7359.
   PubMed Web of Science ®Google Scholar
• Vigo, E., H. Muller, E. Prosperini, G. Hateboer, P. Cartwright, M. C. Moroni, and K. Helin. 1999. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol. Cell. Biol. 19: 6379–6395.
   PubMed Web of Science ®Google Scholar
• Vossler, M. R., H. Yao, R. D. York, M. G. Pan, C. S. Rim, and P. J. Stork. 1997. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89: 73–82.
   PubMed Web of Science ®Google Scholar
• Weston, C. R., K. Balmanno, C. Chalmers, K. Hadfield, S. A Molton, R. Ley, E. F. Wagner, and S. J. Cook. 2003. Activation of ERK1/2 by ΔRaf-1:ER* represses Bim expression independently of the JNK or PI3K pathways. Oncogene 22: 1281–1293.
   PubMed Web of Science ®Google Scholar
• Whitehurst, C. E., O. Hakime, J. T. Bruder, U. R. Rapp, and T. D. Geppert. 1995. The MEK kinase activity of the catalytic domain of RAF-1 is regulated independently of Ras binding in T cells. J. Biol. Chem. 270: 5594–5599.
   PubMedGoogle Scholar
• Whitmarsh, A. J., and R. J. Davis. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74: 589–607.
   PubMed Web of Science ®Google Scholar
• Williamson, E. A., G. S. Burgess, P. Eder, S. Litz-Jackson, and H. S. Boswell. 1997. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4. Leukemia 11: 73–85.
   PubMedGoogle Scholar
• Woods, D., D. Parry, H. Cherwinski, E. Bosch, E. Lees, and M. McMahon. 1997. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17: 5598–5611.
   PubMed Web of Science ®Google Scholar
• Wu, J., P. Dent, T. Jelinek, A. Wolfman, M. J. Weber, and T. W. Sturgill. 1993. Inhibition of the EGF-stimulated MAP kinase signalling pathway by adenosine 3′,5′-monophosphate. Science 262: 1065–1069.
   PubMed Web of Science ®Google Scholar
• Zhang, H. S., M. Gavin, A. Dahiya, A. A. Postigo, D. Ma, R. X. Luo, J. W. Harbour, and D. C. Dean. 2000. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101: 79–89.
   PubMed Web of Science ®Google Scholar